Trials / Completed
CompletedNCT02813863
The Drug-drug Interaction of SP2086 and Metformin
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 24 (actual)
- Sponsor
- Jiangsu HengRui Medicine Co., Ltd. · Industry
- Sex
- Male
- Age
- 18 Years – 45 Years
- Healthy volunteers
- Accepted
Summary
This is an open single and self-control study,planning to recruit 24 cases of healthy male volunteers.In the study,subjects were given SP2086 and metformin,and collects blood samples before and after medcine.The purpose is to evaluate the drug interaction between SP2086 and Metformin.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | SP2086 | |
| DRUG | Metformin |
Timeline
- Start date
- 2015-12-01
- Primary completion
- 2016-03-01
- First posted
- 2016-06-27
- Last updated
- 2016-06-27
Source: ClinicalTrials.gov record NCT02813863. Inclusion in this directory is not an endorsement.